- Home
- GOSS vs KTF Comparison
GOSS vs KTF Comparison
Compare GOSS & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- KTF
- Stock Information
- Founded
- GOSS 2015
- KTF 1988
- Country
- GOSS United States
- KTF United States
- Employees
- GOSS N/A
- KTF N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- KTF Finance Companies
- Sector
- GOSS Health Care
- KTF Finance
- Exchange
- GOSS Nasdaq
- KTF Nasdaq
- Market Cap
- GOSS 347.8M
- KTF 337.7M
- IPO Year
- GOSS 2019
- KTF N/A
- Fundamental
- Price
- GOSS $2.47
- KTF $8.79
- Analyst Decision
- GOSS Strong Buy
- KTF
- Analyst Count
- GOSS 4
- KTF 0
- Target Price
- GOSS $8.50
- KTF N/A
- AVG Volume (30 Days)
- GOSS 3.1M
- KTF 103.3K
- Earning Date
- GOSS 08-05-2025
- KTF 01-01-0001
- Dividend Yield
- GOSS N/A
- KTF 3.54%
- EPS Growth
- GOSS N/A
- KTF N/A
- EPS
- GOSS N/A
- KTF 0.39
- Revenue
- GOSS $40,237,000.00
- KTF N/A
- Revenue This Year
- GOSS N/A
- KTF N/A
- Revenue Next Year
- GOSS $30.65
- KTF N/A
- P/E Ratio
- GOSS N/A
- KTF $23.10
- Revenue Growth
- GOSS N/A
- KTF N/A
- 52 Week Low
- GOSS $0.66
- KTF $7.40
- 52 Week High
- GOSS $2.65
- KTF $9.12
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- KTF 63.49
- Support Level
- GOSS $2.38
- KTF $8.63
- Resistance Level
- GOSS $2.65
- KTF $8.74
- Average True Range (ATR)
- GOSS 0.15
- KTF 0.06
- MACD
- GOSS 0.03
- KTF 0.02
- Stochastic Oscillator
- GOSS 76.67
- KTF 96.12
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.